1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors.
暂无分享,去创建一个
Thomas R Downs | Julie A Farmer | Gina S. Gerwe | T. Downs | K. Peters | A. Colson | M. Pokross | A. Evdokimov | S. R. Klopfenstein | Artem G Evdokimov | N. Fairweather | Jeffrey J. Neuman | Matthew B. Maier | J. Gray | George E. Stake | Brian W. Howard | Bhavani Kasibhatla | Brian W Howard | Kevin G Peters | Anny-Odile Colson | Julie A. Farmer | Bhavani Kasibhatla | Sean R Klopfenstein | Neil T Fairweather | Jeffrey J Neuman | Matthew B Maier | Jeffrey L Gray | Gina S Gerwe | George E Stake | Matthew E Pokross
[1] J. Waring,et al. PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[2] H. Waldmann,et al. Inhibitors of protein tyrosine phosphatases: next-generation drugs? , 2005, Angewandte Chemie.
[3] M. Tremblay,et al. Coordinated action of protein tyrosine phosphatases in insulin signal transduction. , 2002, European journal of biochemistry.
[4] D. Lawrence,et al. Acquisition of a Specific and Potent PTP1B Inhibitor from a Novel Combinatorial Library and Screening Procedure* , 2001, The Journal of Biological Chemistry.
[5] D S Lawrence,et al. Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[6] D S Lawrence,et al. Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition. , 2000, Biochemistry.
[7] Gang Liu. Protein tyrosine phosphatase 1B inhibition: opportunities and challenges. , 2003, Current medicinal chemistry.
[8] M. Blaskovich,et al. Recent discovery and development of protein tyrosine phosphatase inhibitors , 2002 .
[9] C. Bayly,et al. The YRD Motif Is a Major Determinant of Substrate and Inhibitor Specificity in T-cell Protein-tyrosine Phosphatase* , 2001, The Journal of Biological Chemistry.
[10] E. Fritzen,et al. The solid phase synthesis of tetrahydroisoquinolines having cdc25B inhibitory activity. , 2000, Bioorganic & medicinal chemistry letters.
[11] M. Girgis,et al. Using mixed anhydrides from amino acids and isobutyl chloroformate in N-acylations: a case study on the elucidation of mechanism of urethane formation and starting amino acid liberation using carbon dioxide as the probe , 2003 .
[12] B. Kennedy,et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.
[13] Young-Bum Kim,et al. Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice , 2000, Molecular and Cellular Biology.